CCNY, TechnoVax translational research leads to potential Zika virus vaccine

(City College of New York) Preclinical results of research by City College of New York scientists and TechnoVax, Inc. in animal models demonstrate favorable outcomes in developing a vaccine against the mosquito-borne Zika virus. The results were announced by Tarrytown, New York-based TechnoVax, a biotechnology developer of novel vaccines whose proprietary virus-like particle (VLP) is the center of the research.
Source: EurekAlert! - Biology - Category: Biology Source Type: news